PB21

ICD-11 MMS 2026-01

Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants

Index terms

  • Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants
  • accidental overdose by sedative hypnotic drugs or other CNS depressants
  • accidental poisoning by sedative hypnotic drugs or other CNS depressants
Show allHide
  • sedative hypnotic drugs or other CNS depressants taken in error
  • Unintentional exposure to or harmful effects of sedative-hypnotic drugs
  • Unintentional exposure to or harmful effects of barbiturates
  • Unintentional exposure to or harmful effects of benzodiazepines
  • Unintentional exposure to or harmful effects of cloral derivatives
  • Unintentional exposure to or harmful effects of paraldehyde
  • Unintentional exposure to or harmful effects of bromine compounds
  • Unintentional exposure to or harmful effects of mixed sedatives or hypnotics, not elsewhere classified
  • Unintentional exposure to or harmful effects of anaesthetics or therapeutic gases
  • Unintentional exposure to or harmful effects of nitrous oxide
  • Unintentional exposure to or harmful effects of other inhaled anaesthetics
  • Unintentional exposure to or harmful effects of intravenous anaesthetics
  • Unintentional exposure to or harmful effects of unspecified general anaesthetics
  • Unintentional exposure to or harmful effects of gamma hydroxybutyrate
  • Unintentional exposure to or harmful effects of GHB
  • Unintentional exposure to or harmful effects of ketamine
  • Unintentional exposure to or harmful effects of other specified general anaesthetic
  • Unintentional exposure to or harmful effects of local anaesthetics

Inclusions

  • accidental overdose by sedative hypnotic drugs or other CNS depressants

Excludes

  • http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm in therapeutic use

Sibling codes

  • PB20 – Unintentional exposure to or harmful effects of opioids or related analgesics
  • PB22 – Unintentional exposure to or harmful effects of psychostimulants
  • PB23 – Unintentional exposure to or harmful effects of cannabinoids or hallucinogens
  • PB24 – Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
  • PB25 – Unintentional exposure to or harmful effects of antidepressants
  • PB26 – Unintentional exposure to or harmful effects of antipsychotics
  • PB27 – Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
  • PB28 – Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance
  • PB29 – Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances

Foundation entity

Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants – http://id.who.int/icd/entity/730323782

Allowed postcoordination axes

Part of: 23: External causes of morbidity or mortality